PLAT.adhesion: Studies
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 232 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.
| # | Trait / study | Individual trait ID | Mean IC score |
|---|---|---|---|
| 1 | Platelet count | GCST90002402 | 89.77 |
| 2 | Reticulocyte fraction of red cells | GCST004619 | 87.69 |
| 3 | CPXM1/LGMN ratio | GCST90314220 | 83.35 |
| 4 | Reticulocyte percentage (UKB data field 30240) | GCST90468101 | 82.74 |
| 5 | Platelet distribution width | GCST004616 | 79.96 |
| 6 | Reticulocyte percentage | Blood count | UKBB00000753 | 77.31 |
| 7 | Platelet count (UKB data field 30080) | GCST90468095 | 76.90 |
| 8 | mean platelet volume (MPV, maximum, inv-norm transformed) | GCST90475517 | 76.08 |
| 9 | platelet count (minimum, inv-norm transformed) | GCST90476302 | 74.91 |
| 10 | Platelet distribution width | GCST90002401 | 74.04 |
| 11 | Reticulocyte fraction of red cells | GCST90002406 | 73.32 |
| 12 | Platelet count | GCST004603 | 72.84 |
| 13 | High light scatter reticulocyte count (UKB data field 30300) | GCST90468076 | 70.83 |
| 14 | Platelet distribution width (UKB data field 30110) | GCST90468097 | 70.51 |
| 15 | High light scatter reticulocyte percentage (UKB data field 30290) | GCST90468077 | 70.39 |
| 16 | Mean platelet volume | GCST004599 | 70.39 |
| 17 | High light scatter reticulocyte percentage of red cells | GCST90002386 | 70.29 |
| 18 | Mean platelet volume | GCST90002395 | 68.22 |
| 19 | SERPINE1 levels | GCST90470596 | 68.09 |
| 20 | Reticulocyte count | GCST004622 | 67.86 |
| 21 | Platelet distribution width | Blood count | UKBB00000648 | 66.53 |
| 22 | platelet count (mean, inv-norm transformed) | GCST90476299 | 66.35 |
| 23 | platelet count (maximum, inv-norm transformed) | GCST90476296 | 64.84 |
| 24 | Platelet count | Blood count | UKBB00000646 | 62.95 |
| 25 | Reticulocyte count (UKB data field 30250) | GCST90468100 | 62.71 |
| 26 | High light scatter reticulocyte count | GCST90002385 | 61.07 |
| 27 | High light scatter reticulocyte percentage | Blood count | UKBB00000327 | 60.74 |
| 28 | Mean platelet thrombocyte volume (UKB data field 30100) | GCST90468087 | 60.07 |
| 29 | Mean platelet (thrombocyte) volume | Blood count | UKBB00000450 | 59.44 |
| 30 | HBEGF/WWP2 ratio | GCST90315038 | 58.36 |
| 31 | Mean platelet volume during first trimester of pregnancy | GCST90302229 | 57.68 |
| 32 | High light scatter reticulocyte count | Blood count | UKBB00000326 | 57.45 |
| 33 | PDGFA levels | GCST90470188 | 57.18 |
| 34 | ANGPT1 levels | GCST90468300 | 57.09 |
| 35 | Platelet count at delivery | GCST90302227 | 54.90 |
| 36 | High light scatter reticulocyte count | GCST004611 | 54.28 |
| 37 | Mean platelet volume during second trimester of pregnancy | GCST90302230 | 53.44 |
| 38 | Reticulocyte count | GCST90002405 | 52.95 |
| 39 | SPARC levels | GCST90470718 | 52.89 |
| 40 | HBEGF/PLXNA4 ratio | GCST90315036 | 52.60 |
| 41 | CPXM1 levels | GCST90468849 | 51.52 |
| 42 | SDC4/SERPINE1 ratio | GCST90315819 | 50.92 |
| 43 | Reticulocyte count | Blood count | UKBB00000752 | 50.59 |
| 44 | CCN4 levels | GCST90468590 | 50.12 |
| 45 | High light scatter reticulocyte percentage of red cells | GCST004612 | 48.91 |
| 46 | CPXM1/HBEGF ratio | GCST90314219 | 48.48 |
| 47 | DAG1/HBEGF ratio | GCST90314376 | 47.56 |
| 48 | Platelet count | GCST90002358 | 46.69 |
| 49 | GP1BA/SDC4 ratio | GCST90314957 | 45.24 |
| 50 | EDAR/SPARC ratio | GCST90314588 | 44.80 |
| 51 | Blood cell traits latent factor 18 (platelet) | GCST90559260 | 44.79 |
| 52 | PDGFB levels | GCST90470189 | 44.38 |
| 53 | CCL8 levels | GCST90468586 | 44.28 |
| 54 | JAM2/TNFRSF14 ratio | GCST90315240 | 44.23 |
| 55 | ARHGAP1/SPARC ratio | GCST90313344 | 43.57 |
| 56 | Mean platelet volume during third trimester of pregnancy | GCST90302231 | 43.39 |
| 57 | HGF/PDGFB ratio | GCST90315058 | 43.00 |
| 58 | SDC4/SELP ratio | GCST90315817 | 42.91 |
| 59 | ANGPT1/CPXM1 ratio | GCST90313262 | 42.78 |
| 60 | MGLL levels | GCST90469901 | 41.71 |
| 61 | ITGB1BP2 levels | GCST90469642 | 41.59 |
| 62 | MCFD2 levels | GCST90469873 | 41.16 |
| 63 | PDGFB/ST6GAL1 ratio | GCST90315630 | 40.75 |
| 64 | COMT levels | GCST90468828 | 40.44 |
| 65 | HCLS1/TMSB10 ratio | GCST90315043 | 40.22 |
| 66 | APP levels | GCST90468344 | 40.04 |
| 67 | DNPH1/PDGFB ratio | GCST90314527 | 40.00 |
| 68 | BLMH/SERPINE1 ratio | GCST90313520 | 39.64 |
| 69 | HCLS1 levels | GCST90469437 | 39.38 |
| 70 | PTPN6 levels | GCST90470377 | 39.25 |
| 71 | ANXA4 levels | GCST90468319 | 39.16 |
| 72 | FGF2/HBEGF ratio | GCST90314811 | 39.12 |
| 73 | Plateletcrit | GCST004607 | 39.02 |
| 74 | TACC3 levels | GCST90470797 | 38.89 |
| 75 | PDGFA/SCARF1 ratio | GCST90315617 | 38.75 |
| 76 | CD63 levels | GCST90468642 | 38.49 |
| 77 | CIAPIN1/SPARC ratio | GCST90314069 | 38.29 |
| 78 | EREG/HBEGF ratio | GCST90314702 | 38.29 |
| 79 | Plateletcrit | GCST90002400 | 38.17 |
| 80 | FGR/LBR ratio | GCST90314814 | 38.02 |
| 81 | ESAM/JAM2 ratio | GCST90314712 | 37.96 |
| 82 | CD84/DAG1 ratio | GCST90313910 | 37.78 |
| 83 | Platelet crit (UKB data field 30090) | GCST90468096 | 37.75 |
| 84 | CD226 levels | GCST90468609 | 37.69 |
| 85 | EBAG9/HBEGF ratio | GCST90314565 | 37.54 |
| 86 | SELP levels | GCST90470569 | 37.40 |
| 87 | AXIN1/GOPC ratio | GCST90313407 | 37.33 |
| 88 | F2R/MPIG6B ratio | GCST90314732 | 37.28 |
| 89 | DAG1/PDGFB ratio | GCST90314379 | 37.05 |
| 90 | PDGFB/SDC4 ratio | GCST90315626 | 36.71 |
| 91 | F2R/PDGFB ratio | GCST90314733 | 36.53 |
| 92 | VEGFC levels | GCST90471036 | 36.02 |
| 93 | CD63/EDAR ratio | GCST90313864 | 35.92 |
| 94 | TNFAIP8L2 levels | GCST90470897 | 35.36 |
| 95 | FXYD5 levels | GCST90469283 | 35.31 |
| 96 | FIS1/PDGFB ratio | GCST90314830 | 35.31 |
| 97 | HBEGF/SDC4 ratio | GCST90315037 | 35.27 |
| 98 | Cognition and processing speed (confirmatory factor analysis Factor 34) | GCST90309368 | 34.94 |
| 99 | BDNF levels | GCST90468437 | 34.60 |
| 100 | FUT8 levels | GCST90469281 | 34.51 |
| 101 | DKK1 levels | GCST90468997 | 34.28 |
| 102 | MDK levels | GCST90469877 | 34.18 |
| 103 | CA13 levels | GCST90468508 | 34.14 |
| 104 | ANGPT1/CCN2 ratio | GCST90313261 | 34.02 |
| 105 | ANGPT1/PDGFA ratio | GCST90313266 | 33.95 |
| 106 | LGALS8/TXNDC5 ratio | GCST90315321 | 33.93 |
| 107 | STK4 levels | GCST90470767 | 33.25 |
| 108 | DOK2 levels | GCST90469029 | 33.25 |
| 109 | EDAR/TREML2 ratio | GCST90314592 | 33.20 |
| 110 | MAX levels | GCST90469867 | 33.08 |
| 111 | ABHD14B/SPARC ratio | GCST90313146 | 33.00 |
| 112 | F2R/SERPINE1 ratio | GCST90314735 | 32.96 |
| 113 | SERPINB1 levels | GCST90470589 | 32.87 |
| 114 | HBEGF/PDGFB ratio | GCST90315034 | 32.59 |
| 115 | TIMM10 levels | GCST90470867 | 32.58 |
| 116 | APP/VEGFC ratio | GCST90313333 | 32.55 |
| 117 | DKK1/SDC4 ratio | GCST90314479 | 32.33 |
| 118 | GP1BA/HBEGF ratio | GCST90314956 | 32.32 |
| 119 | CD36 levels | GCST90468627 | 32.27 |
| 120 | DAG1/PDGFA ratio | GCST90314378 | 32.14 |
| 121 | HBEGF/PDGFA ratio | GCST90315033 | 32.07 |
| 122 | TREML1 levels | GCST90470961 | 31.96 |
| 123 | CXCL5 levels | GCST90468932 | 31.83 |
| 124 | Platelet count | GCST90278640 | 31.82 |
| 125 | TGFB1 levels | GCST90470843 | 31.42 |
| 126 | PPBP levels | GCST90470289 | 31.24 |
| 127 | Platelet count during third trimester of pregnancy | GCST90302226 | 31.18 |
| 128 | Platelet count | GCST90018749 | 30.91 |
| 129 | GP5 levels | GCST90469383 | 30.90 |
| 130 | RHOC levels | GCST90470467 | 30.56 |
| 131 | EDAR/EGF ratio | GCST90314573 | 30.49 |
| 132 | CD84/F2R ratio | GCST90313912 | 30.31 |
| 133 | TIMP3 levels | GCST90470871 | 30.01 |
| 134 | Monocyte count | Blood count | UKBB00000479 | 29.95 |
| 135 | ESAM/PDGFB ratio | GCST90314714 | 29.87 |
| 136 | ATOX1 levels | GCST90468385 | 29.83 |
| 137 | DECR1 levels | GCST90468978 | 29.79 |
| 138 | MGMT levels | GCST90469902 | 29.75 |
| 139 | CD69 levels | GCST90468643 | 29.60 |
| 140 | AXIN1/DOK2 ratio | GCST90313406 | 29.40 |
| 141 | CASP3 levels | GCST90468545 | 29.38 |
| 142 | SORT1 levels | GCST90470710 | 29.35 |
| 143 | TMSB10 levels | GCST90470894 | 29.27 |
| 144 | PLA2G4A levels | GCST90470248 | 29.14 |
| 145 | DIABLO levels | GCST90468994 | 29.13 |
| 146 | PEAR1 levels | GCST90470204 | 28.99 |
| 147 | DNAJB6 levels | GCST90469014 | 28.99 |
| 148 | MVK/SERPINE1 ratio | GCST90315505 | 28.94 |
| 149 | LACTB2 levels | GCST90469726 | 28.94 |
| 150 | HBEGF levels | GCST90469433 | 28.86 |
| 151 | EDAR/TMSB10 ratio | GCST90314590 | 28.77 |
| 152 | CD84/SDC4 ratio | GCST90313916 | 28.64 |
| 153 | CRADD/EREG ratio | GCST90314236 | 28.43 |
| 154 | EDAR/PRDX5 ratio | GCST90314583 | 28.22 |
| 155 | METAP1D levels | GCST90469892 | 28.20 |
| 156 | Mean platelet volume during the postpartum period | GCST90302233 | 28.19 |
| 157 | PDGFA/VEGFC ratio | GCST90315622 | 28.16 |
| 158 | MSRA levels | GCST90469951 | 28.04 |
| 159 | TBCB levels | GCST90470813 | 28.01 |
| 160 | S100A4 levels | GCST90470518 | 27.96 |
| 161 | PDGFB/VEGFC ratio | GCST90315635 | 27.87 |
| 162 | SRC/TBL1X ratio | GCST90315884 | 27.68 |
| 163 | SNAP29/SPARC ratio | GCST90315860 | 27.63 |
| 164 | CIAPIN1 levels | GCST90468753 | 27.51 |
| 165 | SCARF1 levels | GCST90470536 | 27.35 |
| 166 | HARS1 levels | GCST90469430 | 27.29 |
| 167 | Mean platelet volume at delivery | GCST90302232 | 27.22 |
| 168 | CXCL6 levels | GCST90468933 | 27.21 |
| 169 | Monocyte count | GCST90002393 | 27.18 |
| 170 | CD84/DKK1 ratio | GCST90313911 | 27.14 |
| 171 | Platelet count during second trimester of pregnancy | GCST90302225 | 27.09 |
| 172 | PLCB2 levels | GCST90470255 | 27.06 |
| 173 | CCN2 levels | GCST90468588 | 26.90 |
| 174 | VTA1 levels | GCST90471058 | 26.87 |
| 175 | CCL17/PDGFB ratio | GCST90313688 | 26.76 |
| 176 | DUT levels | GCST90469054 | 26.76 |
| 177 | APRT/EREG ratio | GCST90313335 | 26.57 |
| 178 | EREG/MPI ratio | GCST90314705 | 26.46 |
| 179 | SDC4/SEMA4D ratio | GCST90315818 | 26.45 |
| 180 | CXCL5/SDC4 ratio | GCST90314353 | 26.43 |
| 181 | LAT/SPARC ratio | GCST90315288 | 26.42 |
| 182 | SNAP29 levels | GCST90470692 | 26.36 |
| 183 | MAP4K5 levels | GCST90469855 | 26.33 |
| 184 | DAG1 levels | GCST90468943 | 26.31 |
| 185 | VAV3 levels | GCST90471030 | 26.31 |
| 186 | CD164/LGMN ratio | GCST90313741 | 26.30 |
| 187 | LAMA4/PDGFB ratio | GCST90315273 | 26.26 |
| 188 | SERPINE1/SMAD1 ratio | GCST90315833 | 26.26 |
| 189 | Monocyte count (UKB data field 30130) | GCST90468090 | 26.25 |
| 190 | PDGFA/PLA2G4A ratio | GCST90315615 | 26.24 |
| 191 | Platelet crit | Blood count | UKBB00000647 | 26.22 |
| 192 | AKR1B1 levels | GCST90468273 | 26.21 |
| 193 | HEXIM1 levels | GCST90469447 | 26.13 |
| 194 | CEP20 levels | GCST90468712 | 26.11 |
| 195 | CXCL5/EDAR ratio | GCST90314349 | 26.11 |
| 196 | EDAR/PSRC1 ratio | GCST90314584 | 25.91 |
| 197 | NIT2 levels | GCST90470051 | 25.90 |
| 198 | ENO1 levels | GCST90469109 | 25.89 |
| 199 | Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activity | UKBB00000871 | 25.87 |
| 200 | ANXA3/EDAR ratio | GCST90313280 | 25.79 |
| 201 | APP/DAG1 ratio | GCST90313320 | 25.74 |
| 202 | CCN2/HBEGF ratio | GCST90313713 | 25.72 |
| 203 | Duration screen displayed | Prospective memory | UKBB00000201 | 25.63 |
| 204 | DBNL levels | GCST90468951 | 25.56 |
| 205 | HSPB1 levels | GCST90469489 | 25.53 |
| 206 | CRADD/FADD ratio | GCST90314237 | 25.50 |
| 207 | PDGFA/SNAP23 ratio | GCST90315619 | 25.41 |
| 208 | SRC levels | GCST90470741 | 25.38 |
| 209 | TIMP1 levels | GCST90470869 | 25.35 |
| 210 | PIK3AP1 levels | GCST90470233 | 25.35 |
| 211 | LGMN levels | GCST90469766 | 25.17 |
| 212 | MESD levels | GCST90469891 | 25.15 |
| 213 | SUGT1 levels | GCST90470780 | 25.04 |
| 214 | PLXNA4/SKAP2 ratio | GCST90315685 | 25.00 |
| 215 | HPCAL1 levels | GCST90469471 | 24.86 |
| 216 | TXNRD1 levels | GCST90470994 | 24.82 |
| 217 | ANGPT1/DKK1 ratio | GCST90313263 | 24.64 |
| 218 | ZBTB16 levels | GCST90471095 | 24.63 |
| 219 | APP/NID1 ratio | GCST90313326 | 24.56 |
| 220 | ATOX1/SPARC ratio | GCST90313375 | 24.56 |
| 221 | PLPBP levels | GCST90470260 | 24.52 |
| 222 | CCL13 levels | GCST90468565 | 24.49 |
| 223 | SPART levels | GCST90470719 | 24.49 |
| 224 | FUT8/SORT1 ratio | GCST90314892 | 24.45 |
| 225 | CCL5/RARRES2 ratio | GCST90313704 | 24.44 |
| 226 | CMC1 levels | GCST90468794 | 24.40 |
| 227 | CCL22/PDGFB ratio | GCST90313692 | 24.36 |
| 228 | CD40LG/EDAR ratio | GCST90313818 | 24.28 |
| 229 | ANGPT1/APP ratio | GCST90313260 | 24.27 |
| 230 | BACH1/PDLIM7 ratio | GCST90313445 | 24.25 |
| 231 | NUDC levels | GCST90470102 | 24.23 |
| 232 | MANF levels | GCST90469846 | 24.11 |
| 233 | F2R levels | GCST90469168 | 24.09 |
| 234 | IGF2R/LGMN ratio | GCST90315131 | 24.09 |
| 235 | Blood cell traits latent factor 5 (platelet) | GCST90559247 | 23.93 |
| 236 | FUT8/TNFSF12 ratio | GCST90314894 | 23.86 |
| 237 | EDAR/F2R ratio | GCST90314577 | 23.85 |
| 238 | TBL1X levels | GCST90470815 | 23.84 |
| 239 | LYN levels | GCST90469826 | 23.81 |
| 240 | CRKL levels | GCST90468867 | 23.78 |
| 241 | ENO2 levels | GCST90469110 | 23.78 |
| 242 | TMEM106A levels | GCST90470886 | 23.77 |
| 243 | SPINT2 levels | GCST90470728 | 23.71 |
| 244 | RWDD1 levels | GCST90470510 | 23.68 |
| 245 | ATP5IF1 levels | GCST90468392 | 23.67 |
| 246 | CDKN1A/HBEGF ratio | GCST90313972 | 23.55 |
| 247 | PDGFA/SERPINE1 ratio | GCST90315618 | 23.40 |
| 248 | GIPC3 levels | GCST90469348 | 23.36 |
| 249 | CDC37 levels | GCST90468665 | 23.34 |
| 250 | Immature reticulocyte fraction (UKB data field 30280) | GCST90468079 | 23.31 |
| 251 | PDGFB/SPARC ratio | GCST90315628 | 23.26 |
| 252 | PRKAR1A levels | GCST90470326 | 23.00 |
| 253 | ARHGAP1 levels | GCST90468352 | 22.96 |
| 254 | ABL1/PDLIM7 ratio | GCST90313150 | 22.90 |
| 255 | CLTA levels | GCST90468791 | 22.85 |
| 256 | NFU1 levels | GCST90470040 | 22.84 |
| 257 | PPIB levels | GCST90470291 | 22.58 |
| 258 | IGSF8 levels | GCST90469540 | 22.56 |
| 259 | CD40 levels | GCST90468633 | 22.52 |
| 260 | SKAP2 levels | GCST90470646 | 22.43 |
| 261 | SNAP23 levels | GCST90470690 | 22.35 |
| 262 | SDC4 levels | GCST90470559 | 22.34 |
| 263 | GP1BA levels | GCST90469380 | 22.29 |
| 264 | CIRBP levels | GCST90468756 | 22.22 |
| 265 | ITGB5/SIAE ratio | GCST90315234 | 22.18 |
| 266 | monocyte (absolute count, mean, inv-norm transformed) | GCST90475502 | 22.17 |
| 267 | CCL13/CCL2 ratio | GCST90313675 | 22.17 |
| 268 | USO1 levels | GCST90471018 | 22.16 |
| 269 | EDAR levels | GCST90469068 | 22.13 |
| 270 | ADD1 levels | GCST90468233 | 22.13 |
| 271 | PRTFDC1 levels | GCST90470346 | 22.11 |
| 272 | CALCOCO1/PDLIM7 ratio | GCST90313607 | 22.08 |
| 273 | CRADD/STAMBP ratio | GCST90314244 | 22.03 |
| 274 | TRIAP1 levels | GCST90470963 | 22.03 |
| 275 | AKT1S1 levels | GCST90468276 | 22.00 |
| 276 | SSNA1 levels | GCST90470750 | 21.96 |
| 277 | PARK7 levels | GCST90470159 | 21.96 |
| 278 | CD46/NID1 ratio | GCST90313833 | 21.88 |
| 279 | COCH levels | GCST90468810 | 21.71 |
| 280 | Platelet count during postpartum period | GCST90302228 | 21.70 |
| 281 | TNFAIP2 levels | GCST90470896 | 21.68 |
| 282 | SERPINE2 levels | GCST90470597 | 21.67 |
| 283 | CCN2/EDAR ratio | GCST90313711 | 21.65 |
| 284 | TPP1 levels | GCST90470946 | 21.63 |
| 285 | SPARC/ZBTB16 ratio | GCST90315875 | 21.59 |
| 286 | EREG/ITGB1BP2 ratio | GCST90314703 | 21.54 |
| 287 | BGN levels | GCST90468441 | 21.46 |
| 288 | FYB1 levels | GCST90469284 | 21.46 |
| 289 | CLEC1B/HBEGF ratio | GCST90314092 | 21.45 |
| 290 | PDGFB/PRKAR1A ratio | GCST90315624 | 21.43 |
| 291 | NCK2 levels | GCST90470007 | 21.39 |
| 292 | NUB1 levels | GCST90470099 | 21.38 |
| 293 | EGFL7 levels | GCST90469083 | 21.31 |
| 294 | CCN2/TPP1 ratio | GCST90313718 | 21.22 |
| 295 | APP/HBEGF ratio | GCST90313324 | 21.19 |
| 296 | GMPR2 levels | GCST90469367 | 21.19 |
| 297 | JAM3 levels | GCST90469660 | 21.15 |
| 298 | DYNLT1 levels | GCST90469057 | 21.07 |
| 299 | NID2 levels | GCST90470048 | 21.04 |
| 300 | FIS1 levels | GCST90469240 | 21.04 |
| 301 | PGD levels | GCST90470217 | 21.03 |
| 302 | Immature fraction of reticulocytes | GCST90002387 | 21.00 |
| 303 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 20.97 |
| 304 | IRAK4 levels | GCST90469628 | 20.89 |
| 305 | DBI/TMSB10 ratio | GCST90314414 | 20.85 |
| 306 | GRAP2 levels | GCST90469399 | 20.82 |
| 307 | PDAP1 levels | GCST90470179 | 20.80 |
| 308 | CACYBP levels | GCST90468524 | 20.80 |
| 309 | ERP29 levels | GCST90469149 | 20.76 |
| 310 | PPM1F levels | GCST90470297 | 20.72 |
| 311 | GADD45GIP1 levels | GCST90469293 | 20.68 |
| 312 | PRDX5 levels | GCST90470318 | 20.68 |
| 313 | VAMP8 levels | GCST90471025 | 20.64 |
| 314 | EDAR/TXNDC5 ratio | GCST90314593 | 20.60 |
| 315 | MECR levels | GCST90469879 | 20.56 |
| 316 | NIT1 levels | GCST90470050 | 20.54 |
| 317 | STAT5B levels | GCST90470759 | 20.52 |
| 318 | SH2B3 levels | GCST90470616 | 20.51 |
| 319 | DCTN1/TRIAP1 ratio | GCST90314434 | 20.50 |
| 320 | DBI levels | GCST90468949 | 20.45 |
| 321 | Mean corpuscular hemoglobin | GCST90018744 | 20.40 |
| 322 | DKK1/PPCDC ratio | GCST90314477 | 20.39 |
| 323 | HBEGF/LAT2 ratio | GCST90315032 | 20.37 |
| 324 | F11R levels | GCST90469164 | 20.36 |
| 325 | CCN2/ENO2 ratio | GCST90313712 | 20.35 |
| 326 | ITGB5 levels | GCST90469645 | 20.33 |
| 327 | HNRNPK levels | GCST90469469 | 20.29 |
| 328 | monocyte (absolute count, maximum, inv-norm transformed) | GCST90475499 | 20.29 |
| 329 | CTF1 levels | GCST90468901 | 20.27 |
| 330 | PLXNA4 levels | GCST90470265 | 20.25 |
| 331 | LRRC59 levels | GCST90469804 | 20.25 |
| 332 | Fluid intelligence score | Fluid intelligence / reasoning | UKBB00000250 | 20.24 |
| 333 | FADD levels | GCST90469180 | 20.24 |
| 334 | ADGRF5 levels | GCST90468239 | 20.13 |
| 335 | Time spent watching television (TV) | Physical activity | UKBB00000821 | 20.08 |
| 336 | FKBP5 levels | GCST90469244 | 20.06 |
| 337 | USP8 levels | GCST90471022 | 20.05 |
| 338 | Monocyte percentage (UKB data field 30190) | GCST90468091 | 20.03 |
| 339 | NT5C3A levels | GCST90470091 | 20.02 |
| 340 | PPP1R2 levels | GCST90470304 | 20.01 |
| 341 | ERBIN levels | GCST90469142 | 20.00 |
| 342 | EDAR/SDC4 ratio | GCST90314585 | 19.97 |
| 343 | Monocyte percentage | Blood count | UKBB00000480 | 19.91 |
| 344 | PDGFB/SPINT2 ratio | GCST90315629 | 19.85 |
| 345 | GPC5 levels | GCST90469387 | 19.83 |
| 346 | PDGFB/TNFSF13 ratio | GCST90315632 | 19.82 |
| 347 | Immature reticulocyte fraction | Blood count | UKBB00000355 | 19.81 |
| 348 | ANXA3 levels | GCST90468318 | 19.79 |
| 349 | SULT1A1 levels | GCST90470781 | 19.78 |
| 350 | FYB1/PDGFB ratio | GCST90314912 | 19.71 |
| 351 | CXCL12/TIMP3 ratio | GCST90314338 | 19.70 |
| 352 | PDGFB/SNAP29 ratio | GCST90315627 | 19.67 |
| 353 | GLRX5 levels | GCST90469361 | 19.67 |
| 354 | LAMA4 levels | GCST90469731 | 19.61 |
| 355 | RAB10 levels | GCST90470403 | 19.59 |
| 356 | FUT8/VEGFC ratio | GCST90314896 | 19.59 |
| 357 | RAB27B levels | GCST90470405 | 19.58 |
| 358 | PFKFB2 levels | GCST90470215 | 19.56 |
| 359 | FLT1/TFPI2 ratio | GCST90314856 | 19.54 |
| 360 | GMFG levels | GCST90469366 | 19.54 |
| 361 | PMVK levels | GCST90470272 | 19.43 |
| 362 | SDC4/WWP2 ratio | GCST90315821 | 19.41 |
| 363 | MED18 levels | GCST90469880 | 19.34 |
| 364 | PF4 levels | GCST90470211 | 19.33 |
| 365 | CDKN2D levels | GCST90468685 | 19.31 |
| 366 | Monocyte count | GCST004625 | 19.30 |
| 367 | CETN2 levels | GCST90468721 | 19.22 |
| 368 | SPARC/TJAP1 ratio | GCST90315873 | 19.18 |
| 369 | MPIG6B levels | GCST90469935 | 19.17 |
| 370 | Mean corpuscular volume | GCST90018746 | 19.14 |
| 371 | CRADD levels | GCST90468854 | 19.13 |
| 372 | TXNDC5 levels | GCST90470991 | 19.13 |
| 373 | LAT/PDGFA ratio | GCST90315285 | 19.09 |
| 374 | Weekly usage of mobile phone in last 3 months | Electronic device use | UKBB00000908 | 19.03 |
| 375 | NRGN levels | GCST90470083 | 18.95 |
| 376 | TDRKH levels | GCST90470827 | 18.93 |
| 377 | APRT levels | GCST90468345 | 18.87 |
| 378 | CXCL3/CXCL5 ratio | GCST90314344 | 18.86 |
| 379 | Sleep duration | Sleep | UKBB00000777 | 18.84 |
| 380 | EEF1D levels | GCST90469075 | 18.81 |
| 381 | AK2 levels | GCST90468270 | 18.80 |
| 382 | ACOT13 levels | GCST90468200 | 18.80 |
| 383 | CPXM1/MDK ratio | GCST90314221 | 18.76 |
| 384 | MAP2 levels | GCST90469853 | 18.70 |
| 385 | CD46/SELP ratio | GCST90313834 | 18.58 |
| 386 | EDAR/ITGB1BP2 ratio | GCST90314580 | 18.57 |
| 387 | Principal component-derived dietary pattern 13 | GCST90133018 | 18.55 |
| 388 | VSIR levels | GCST90471053 | 18.51 |
| 389 | Neuroticism | GCST003770 | 18.47 |
| 390 | PDGFB/PPP1R12A ratio | GCST90315623 | 18.47 |
| 391 | SERPINB6 levels | GCST90470591 | 18.46 |
| 392 | EBAG9 levels | GCST90469059 | 18.44 |
| 393 | ITGB1BP2/MED18 ratio | GCST90315213 | 18.44 |
| 394 | EDAR/F11R ratio | GCST90314576 | 18.43 |
| 395 | EGF levels | GCST90469086 | 18.42 |
| 396 | MYDGF levels | GCST90469972 | 18.42 |
| 397 | LAT levels | GCST90469741 | 18.40 |
| 398 | Monocyte percentage of white cells | GCST004609 | 18.39 |
| 399 | DAAM1 levels | GCST90468941 | 18.37 |
| 400 | CCL28 levels | GCST90468580 | 18.36 |
| 401 | PVALB levels | GCST90470393 | 18.34 |
| 402 | CCL17/GRK5 ratio | GCST90313687 | 18.32 |
| 403 | FXN levels | GCST90469282 | 18.30 |
| 404 | PDGFB/UXS1 ratio | GCST90315634 | 18.27 |
| 405 | GP6 levels | GCST90469384 | 18.26 |
| 406 | MPIG6B/SUSD1 ratio | GCST90315487 | 18.26 |
| 407 | EREG levels | GCST90469145 | 18.23 |
| 408 | SERPINB9 levels | GCST90470593 | 18.17 |
| 409 | Granulocyte percentage of myeloid white cells | GCST004608 | 18.16 |
| 410 | MARS1 levels | GCST90469862 | 18.15 |
| 411 | CD84/SORT1 ratio | GCST90313918 | 18.15 |
| 412 | DFFA levels | GCST90468987 | 18.12 |
| 413 | DDHD2 levels | GCST90468968 | 18.12 |
| 414 | LBR levels | GCST90469744 | 18.10 |
| 415 | CXCL5/PLXNA4 ratio | GCST90314351 | 18.09 |
| 416 | EREG/F2R ratio | GCST90314700 | 18.05 |
| 417 | MPI levels | GCST90469936 | 18.02 |
| 418 | Inflammatory markers and poor diet (confirmatory factor analysis Factor 30) | GCST90309364 | 17.99 |
| 419 | HPSE levels | GCST90469473 | 17.97 |
| 420 | ARHGAP25 levels | GCST90468353 | 17.95 |
| 421 | CXCL11/CXCL13 ratio | GCST90314333 | 17.94 |
| 422 | Pulmonary heart disease (PheCode 415) | GCST90475942 | 17.91 |
| 423 | CASP3/PDGFA ratio | GCST90313637 | 17.91 |
| 424 | BCL2L1 levels | GCST90468432 | 17.90 |
| 425 | LZTFL1 levels | GCST90469834 | 17.89 |
| 426 | MCEMP1 levels | GCST90469872 | 17.87 |
| 427 | BLVRB/CA3 ratio | GCST90313523 | 17.87 |
| 428 | FKBP1B levels | GCST90469242 | 17.86 |
| 429 | Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels | GCST90060273 | 17.85 |
| 430 | CD69/SNAP23 ratio | GCST90313886 | 17.85 |
| 431 | SIAE levels | GCST90470629 | 17.81 |
| 432 | CD40/TNFRSF14 ratio | GCST90313830 | 17.80 |
| 433 | CXCL5/PPIB ratio | GCST90314352 | 17.75 |
| 434 | EGF/MGLL ratio | GCST90314610 | 17.73 |
| 435 | LDLRAP1 levels | GCST90469749 | 17.73 |
| 436 | ESAM/FUT8 ratio | GCST90314711 | 17.70 |
| 437 | EIF4E levels | GCST90469096 | 17.67 |
| 438 | ANXA11 levels | GCST90468315 | 17.63 |
| 439 | Mean corpuscular hemoglobin | GCST90002323 | 17.62 |
| 440 | DNAJC6 levels | GCST90469017 | 17.62 |
| 441 | TBCA levels | GCST90470812 | 17.59 |
| 442 | GRSF1 levels | GCST90469407 | 17.58 |
| 443 | CLEC7A levels | GCST90468778 | 17.56 |
| 444 | SNAP23/SNAP29 ratio | GCST90315855 | 17.53 |
| 445 | Neutrophil count | GCST90002351 | 17.51 |
| 446 | ITGB1/SELP ratio | GCST90315230 | 17.45 |
| 447 | EDAR/IPCEF1 ratio | GCST90314578 | 17.45 |
| 448 | IL7 levels | GCST90469606 | 17.45 |
| 449 | FUT8/PDGFA ratio | GCST90314890 | 17.41 |
| 450 | HS1BP3 levels | GCST90469477 | 17.39 |
| 451 | PDLIM7/PLA2G4A ratio | GCST90315637 | 17.39 |
| 452 | APRT/CD63 ratio | GCST90313334 | 17.39 |
| 453 | DAG1/MGLL ratio | GCST90314377 | 17.39 |
| 454 | CALCOCO2 levels | GCST90468531 | 17.31 |
| 455 | NMI levels | GCST90470056 | 17.30 |
| 456 | CLEC1B/PLXNA4 ratio | GCST90314100 | 17.27 |
| 457 | CLEC1B/EGF ratio | GCST90314089 | 17.24 |
| 458 | SUMF2 levels | GCST90470784 | 17.23 |
| 459 | NT5C3A/PRDX5 ratio | GCST90315567 | 17.19 |
| 460 | Paroxysmal supraventricular tachycardia (PheCode 427.11) | GCST90475964 | 17.16 |
| 461 | CASP3/PDGFB ratio | GCST90313638 | 17.16 |
| 462 | COMMD1 levels | GCST90468825 | 17.15 |
| 463 | FKBP14 levels | GCST90469241 | 17.15 |
| 464 | NAGK levels | GCST90469995 | 17.14 |
| 465 | monocyte (fraction, maximum, inv-norm transformed) | GCST90475508 | 17.14 |
| 466 | DOK2/PDLIM7 ratio | GCST90314535 | 17.10 |
| 467 | L3HYPDH levels | GCST90469724 | 17.05 |
| 468 | PLIN3/TYMP ratio | GCST90315678 | 17.04 |
| 469 | CASP3/SNAP23 ratio | GCST90313644 | 17.03 |
| 470 | RHOC/TBCB ratio | GCST90315774 | 16.99 |
| 471 | ANGPT1/MPIG6B ratio | GCST90313265 | 16.96 |
| 472 | EVI5 levels | GCST90469158 | 16.92 |
| 473 | APP/LAMA4 ratio | GCST90313325 | 16.90 |
| 474 | CXCL8 levels | GCST90468934 | 16.89 |
| 475 | SORT1/ST6GAL1 ratio | GCST90315869 | 16.88 |
| 476 | CETN3 levels | GCST90468722 | 16.85 |
| 477 | SEMA4D levels | GCST90470573 | 16.82 |
| 478 | Myeloid white cell count | GCST004626 | 16.81 |
| 479 | COL2A1 levels | GCST90468816 | 16.79 |
| 480 | IDP dMRI ProbtrackX L1 ilf l | GCST90004260 | 16.78 |
| 481 | Neutrophil count | GCST90002398 | 16.78 |
| 482 | Monocyte count | GCST90025950 | 16.74 |
| 483 | PDGFA/SPARC ratio | GCST90315620 | 16.71 |
| 484 | Bipolar and major depression status - No Bipolar or Depression | Mental health | UKBB00000094 | 16.71 |
| 485 | BIRC2/CD40LG ratio | GCST90313517 | 16.71 |
| 486 | TBCC levels | GCST90470814 | 16.71 |
| 487 | FGD3 levels | GCST90469217 | 16.70 |
| 488 | WWP2 levels | GCST90471080 | 16.64 |
| 489 | CD69/F2R ratio | GCST90313877 | 16.55 |
| 490 | PSRC1/SORT1 ratio | GCST90315742 | 16.54 |
| 491 | CASP8 levels | GCST90468548 | 16.51 |
| 492 | PLXNB3 levels | GCST90470267 | 16.46 |
| 493 | ITGB1BP2/PTPN6 ratio | GCST90315218 | 16.45 |
| 494 | RILPL2 levels | GCST90470470 | 16.41 |
| 495 | PLA2G4A/SDC4 ratio | GCST90315668 | 16.39 |
| 496 | PHACTR2 levels | GCST90470224 | 16.38 |
| 497 | CXCL12 levels | GCST90468925 | 16.36 |
| 498 | CD69/EDAR ratio | GCST90313875 | 16.34 |
| 499 | CCL14 levels | GCST90468566 | 16.32 |
| 500 | DKK1/LGALS8 ratio | GCST90314472 | 16.31 |
| 501 | EDAR/SERPINB1 ratio | GCST90314586 | 16.28 |
| 502 | Neutrophill count (UKB data field 30140) | GCST90468092 | 16.25 |
| 503 | TIMM8A levels | GCST90470868 | 16.24 |
| 504 | ANGPT1/SERPINE1 ratio | GCST90313269 | 16.23 |
| 505 | EDAR/IRAK4 ratio | GCST90314579 | 16.16 |
| 506 | SLC9A3R1 levels | GCST90470665 | 16.11 |
| 507 | AKT3 levels | GCST90468278 | 16.11 |
| 508 | RSPO1/RSPO3 ratio | GCST90315790 | 16.10 |
| 509 | HTRA2 levels | GCST90469494 | 16.10 |
| 510 | TNFSF12 levels | GCST90470919 | 16.09 |
| 511 | DIABLO/PDGFB ratio | GCST90314468 | 16.09 |
| 512 | CRELD2 levels | GCST90468859 | 16.06 |
| 513 | TMSB10/TRIAP1 ratio | GCST90315924 | 16.01 |
| 514 | DOK1 levels | GCST90469028 | 15.92 |
| 515 | Monocyte percentage of white cells | GCST90002394 | 15.91 |
| 516 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 15.89 |
| 517 | CCL17/CCL22 ratio | GCST90313682 | 15.82 |
| 518 | NID1/TIMP3 ratio | GCST90315543 | 15.80 |
| 519 | NID1 levels | GCST90470047 | 15.80 |
| 520 | GALNT10/TNFSF12 ratio | GCST90314916 | 15.78 |
| 521 | Neutrophil count | GCST004629 | 15.78 |
| 522 | DTD1 levels | GCST90469045 | 15.77 |
| 523 | SCAMP3 levels | GCST90470532 | 15.72 |
| 524 | CXCL5/SERPINE1 ratio | GCST90314354 | 15.70 |
| 525 | PPP1R12A levels | GCST90470300 | 15.68 |
| 526 | EGF/PPIB ratio | GCST90314612 | 15.67 |
| 527 | APEX1/LSP1 ratio | GCST90313307 | 15.62 |
| 528 | GCC1 levels | GCST90469315 | 15.61 |
| 529 | VEGFA levels | GCST90471034 | 15.61 |
| 530 | THPO levels | GCST90470857 | 15.52 |
| 531 | EIF4G1 levels | GCST90469097 | 15.49 |
| 532 | DAG1/F2R ratio | GCST90314374 | 15.46 |
| 533 | Granulocyte count | GCST004614 | 15.42 |
| 534 | MTDH levels | GCST90469954 | 15.40 |
| 535 | DCTD levels | GCST90468957 | 15.38 |
| 536 | Sum neutrophil eosinophil counts | GCST004613 | 15.37 |
| 537 | ACADSB levels | GCST90468195 | 15.33 |
| 538 | DBNL/PDGFB ratio | GCST90314422 | 15.30 |
| 539 | neutrophil (absolute count, minimum, inv-norm transformed) | GCST90475532 | 15.29 |
| 540 | NUDT5 levels | GCST90470107 | 15.29 |
| 541 | Sum basophil neutrophil counts | GCST004620 | 15.29 |
| 542 | TFPI2 levels | GCST90470838 | 15.27 |
| 543 | Principal component-derived dietary pattern 8 | GCST90133013 | 15.26 |
| 544 | LAT/SERPINE1 ratio | GCST90315287 | 15.24 |
| 545 | AKT1S1/MAX ratio | GCST90313230 | 15.23 |
| 546 | CCL14/CST3 ratio | GCST90313679 | 15.18 |
| 547 | DAPP1 levels | GCST90468946 | 15.16 |
| 548 | EDAR/ENO2 ratio | GCST90314574 | 15.14 |
| 549 | CASP3/SERPINE1 ratio | GCST90313643 | 15.13 |
| 550 | ITPR1 levels | GCST90469655 | 15.10 |
| 551 | AXIN1/INPPL1 ratio | GCST90313410 | 15.09 |
| 552 | FAM172A levels | GCST90469184 | 15.09 |
| 553 | HBEGF/YES1 ratio | GCST90315039 | 15.09 |
| 554 | Principal component-derived dietary pattern 46 | GCST90133051 | 15.08 |
| 555 | AXL/VCAM1 ratio | GCST90313423 | 15.06 |
| 556 | CSNK2A1 levels | GCST90468889 | 15.03 |
| 557 | CNST levels | GCST90468801 | 14.98 |
| 558 | TBCB/TBCC ratio | GCST90315909 | 14.97 |
| 559 | GP6/TMSB10 ratio | GCST90314975 | 14.97 |
| 560 | PCBP2 levels | GCST90470167 | 14.95 |
| 561 | CDKN2D/FOXO1 ratio | GCST90313985 | 14.93 |
| 562 | APPL2 levels | GCST90468343 | 14.93 |
| 563 | COL5A1 levels | GCST90468820 | 14.90 |
| 564 | CLPP levels | GCST90468785 | 14.90 |
| 565 | CRADD/EDAR ratio | GCST90314235 | 14.86 |
| 566 | DNAJA2 levels | GCST90469009 | 14.83 |
| 567 | LGALS8 levels | GCST90469764 | 14.80 |
| 568 | CRYZL1 levels | GCST90468878 | 14.76 |
| 569 | EREG/TIMP3 ratio | GCST90314708 | 14.73 |
| 570 | IPCEF1/SPARC ratio | GCST90315186 | 14.72 |
| 571 | Blood cell traits latent factor 16 (white cell) | GCST90559258 | 14.71 |
| 572 | TJAP1 levels | GCST90470874 | 14.71 |
| 573 | CCN2/DKK1 ratio | GCST90313710 | 14.70 |
| 574 | CD84/SEMA4D ratio | GCST90313917 | 14.69 |
| 575 | PDE5A levels | GCST90470187 | 14.67 |
| 576 | CPXM1/DKK1 ratio | GCST90314218 | 14.64 |
| 577 | GLOD4 levels | GCST90469359 | 14.63 |
| 578 | CNST/DOK2 ratio | GCST90314157 | 14.61 |
| 579 | GBP2 levels | GCST90469312 | 14.57 |
| 580 | Depression | GCST003769 | 14.55 |
| 581 | Fluid intelligence score (baseline) | GCST90565842 | 14.54 |
| 582 | ITGB1BP2/LAT2 ratio | GCST90315212 | 14.53 |
| 583 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475458 | 14.45 |
| 584 | TPD52L2 levels | GCST90470942 | 14.45 |
| 585 | Platelet count during first trimester of pregnancy | GCST90302224 | 14.43 |
| 586 | PDGFA/PRSS27 ratio | GCST90315616 | 14.40 |
| 587 | Conditional arithmetic | Fluid intelligence / reasoning | UKBB00000145 | 14.40 |
| 588 | Neutrophill count | Blood count | UKBB00000497 | 14.39 |
| 589 | ITGB1BP2/SKAP2 ratio | GCST90315219 | 14.37 |
| 590 | PLXNA4/SUSD1 ratio | GCST90315689 | 14.36 |
| 591 | Deep vein thrombosis [DVT] (PheCode 452.2) | GCST90476010 | 14.36 |
| 592 | EDAR/TACC3 ratio | GCST90314589 | 14.32 |
| 593 | Gestational thrombocytopenia | GCST90302234 | 14.31 |
| 594 | STK11 levels | GCST90470765 | 14.30 |
| 595 | DOK2/FADD ratio | GCST90314530 | 14.29 |
| 596 | CHAC2 levels | GCST90468736 | 14.28 |
| 597 | KIFBP levels | GCST90469683 | 14.21 |
| 598 | NFKB1 levels | GCST90470037 | 14.19 |
| 599 | MIF levels | GCST90469906 | 14.18 |
| 600 | CD84 levels | GCST90468653 | 14.18 |
| 601 | NPTX1 levels | GCST90470078 | 14.18 |
| 602 | APP/TMSB10 ratio | GCST90313332 | 14.18 |
| 603 | SYAP1 levels | GCST90470792 | 14.17 |
| 604 | Mean corpuscular volume | GCST90002335 | 14.17 |
| 605 | Acetate levels (UKB data field 23475) | GCST90269572 | 14.17 |
| 606 | CLEC1A/CLEC7A ratio | GCST90314083 | 14.13 |
| 607 | PLEKHO1 levels | GCST90470256 | 14.09 |
| 608 | EBAG9/TBCB ratio | GCST90314567 | 14.08 |
| 609 | LONP1 levels | GCST90469785 | 14.05 |
| 610 | CCL2 levels | GCST90468581 | 14.02 |
| 611 | ASRGL1 levels | GCST90468379 | 14.00 |
| 612 | MAP2K1 levels | GCST90469851 | 14.00 |
| 613 | CD40/TIMP3 ratio | GCST90313829 | 13.96 |
| 614 | BIN2/TMSB10 ratio | GCST90313515 | 13.94 |
| 615 | KLK6/PTPRN2 ratio | GCST90315256 | 13.93 |
| 616 | Qualifications - Other professional qualifications eg: nursing, teaching | Education | UKBB00000732 | 13.91 |
| 617 | CD164 levels | GCST90468602 | 13.90 |
| 618 | Feeling hurt | GCST006951 | 13.90 |
| 619 | SARG levels | GCST90470526 | 13.89 |
| 620 | TIA1 levels | GCST90470862 | 13.87 |
| 621 | CORO1A levels | GCST90468832 | 13.85 |
| 622 | Basophil count | GCST90002292 | 13.82 |
| 623 | EDAR/ERBIN ratio | GCST90314575 | 13.79 |
| 624 | EPHB4/ESAM ratio | GCST90314679 | 13.77 |
| 625 | APLP1 levels | GCST90468330 | 13.74 |
| 626 | YWHAQ levels | GCST90471092 | 13.73 |
| 627 | MAVS levels | GCST90469866 | 13.73 |
| 628 | CNPY4 levels | GCST90468800 | 13.71 |
| 629 | WASHC3 levels | GCST90471069 | 13.71 |
| 630 | SIRT2 levels | GCST90470642 | 13.70 |
| 631 | TREML2 levels | GCST90470962 | 13.68 |
| 632 | HDGF levels | GCST90469442 | 13.66 |
| 633 | BIN2/EREG ratio | GCST90313503 | 13.64 |
| 634 | CD40LG levels | GCST90468632 | 13.60 |
| 635 | DNAJA2/PLXNA4 ratio | GCST90314504 | 13.57 |
| 636 | HSPA1A levels | GCST90469487 | 13.55 |
| 637 | AXIN1/MAP2K6 ratio | GCST90313413 | 13.54 |
| 638 | PSIP1 levels | GCST90470354 | 13.53 |
| 639 | CXCL1 levels | GCST90468930 | 13.50 |
| 640 | ITGB1BP2/MITD1 ratio | GCST90315214 | 13.50 |
| 641 | ESAM levels | GCST90469152 | 13.50 |
| 642 | BTN2A1/SPINT2 ratio | GCST90313550 | 13.46 |
| 643 | LBR/MAD1L1 ratio | GCST90315295 | 13.45 |
| 644 | GNE levels | GCST90469370 | 13.44 |
| 645 | PDLIM5 levels | GCST90470197 | 13.40 |
| 646 | CCL11/CCL13 ratio | GCST90313671 | 13.36 |
| 647 | SF3B4 levels | GCST90470609 | 13.35 |
| 648 | STAMBP levels | GCST90470756 | 13.34 |
| 649 | DDX58 levels | GCST90468977 | 13.33 |
| 650 | DAG1/PLA2G4A ratio | GCST90314380 | 13.31 |
| 651 | RABEP1 levels | GCST90470414 | 13.26 |
| 652 | IST1 levels | GCST90469632 | 13.26 |
| 653 | TBC1D23 levels | GCST90470810 | 13.25 |
| 654 | CD164/SIAE ratio | GCST90313744 | 13.25 |
| 655 | CCL5 levels | GCST90468584 | 13.25 |
| 656 | ATP5IF1/METAP1D ratio | GCST90313391 | 13.18 |
| 657 | EGF/MANF ratio | GCST90314609 | 13.16 |
| 658 | PMM2 levels | GCST90470270 | 13.15 |
| 659 | NDUFB7 levels | GCST90470015 | 13.14 |
| 660 | FADD/PPP1R2 ratio | GCST90314774 | 13.13 |
| 661 | Job involves heavy manual or physical work | Employment | UKBB00000383 | 13.13 |
| 662 | PTRHD1 levels | GCST90470389 | 13.13 |
| 663 | Blood cell traits latent factor 7 (white cell) | GCST90559249 | 13.08 |
| 664 | BIN2/PDLIM7 ratio | GCST90313509 | 13.02 |
| 665 | Depression or dysthymia | FING00000400 | 13.00 |
| 666 | NID1/SORT1 ratio | GCST90315542 | 12.99 |
| 667 | TPMT levels | GCST90470945 | 12.97 |
| 668 | AXIN1/MAVS ratio | GCST90313414 | 12.93 |
| 669 | Insomnia (standard GWA) | GCST90267286 | 12.91 |
| 670 | MINK1 levels | GCST90469909 | 12.91 |
| 671 | Falls in the last year | General health | UKBB00000235 | 12.91 |
| 672 | RGCC levels | GCST90470461 | 12.90 |
| 673 | ESAM/SORT1 ratio | GCST90314716 | 12.86 |
| 674 | TNFRSF14 levels | GCST90470907 | 12.85 |
| 675 | TWF2 levels | GCST90470987 | 12.84 |
| 676 | DAPP1/ITGB1BP2 ratio | GCST90314388 | 12.84 |
| 677 | MAVS/RNF41 ratio | GCST90315395 | 12.83 |
| 678 | PEAR1/SPINT2 ratio | GCST90315644 | 12.82 |
| 679 | DXO levels | GCST90469055 | 12.82 |
| 680 | MITD1 levels | GCST90469910 | 12.81 |
| 681 | Paradoxical eczema in biologic-treated plaque psoriasis | GCST90162550 | 12.79 |
| 682 | CCN2/MGLL ratio | GCST90313714 | 12.77 |
| 683 | PSTPIP2 levels | GCST90470366 | 12.77 |
| 684 | CASP7 levels | GCST90468547 | 12.76 |
| 685 | Falling risk | GCST90012857 | 12.74 |
| 686 | ITPA levels | GCST90469654 | 12.72 |
| 687 | SELPLG levels | GCST90012046 | 12.70 |
| 688 | Basophil count variance | GCST90565682 | 12.69 |
| 689 | BCL2L11 levels | GCST90468430 | 12.67 |
| 690 | DNM1 levels | GCST90469021 | 12.65 |
| 691 | ARHGEF1 levels | GCST90468359 | 12.65 |
| 692 | UXS1 levels | GCST90471023 | 12.64 |
| 693 | MANF/SDC4 ratio | GCST90315367 | 12.60 |
| 694 | ENO2/TXNDC5 ratio | GCST90314671 | 12.57 |
| 695 | Other diseases of blood and blood-forming organs | FING00000998 | 12.55 |
| 696 | METAP2 levels | GCST90469894 | 12.54 |
| 697 | YARS1 levels | GCST90471087 | 12.53 |
| 698 | FOXO1/NUB1 ratio | GCST90314874 | 12.50 |
| 699 | White blood cell count | GCST90002407 | 12.46 |
| 700 | ERP44 levels | GCST90469150 | 12.44 |
| 701 | DRG2 levels | GCST90469039 | 12.44 |
| 702 | MANF/PDGFB ratio | GCST90315360 | 12.43 |
| 703 | ELAC1 levels | GCST90469101 | 12.40 |
| 704 | CD46/SIAE ratio | GCST90313835 | 12.39 |
| 705 | CD69/CEP43 ratio | GCST90313867 | 12.37 |
| 706 | GTPBP2 levels | GCST90469417 | 12.36 |
| 707 | Family relationship satisfaction | Mental health | UKBB00000238 | 12.36 |
| 708 | CERT levels | GCST90468717 | 12.34 |
| 709 | DKK1/MGLL ratio | GCST90314473 | 12.33 |
| 710 | EBAG9/EDAR ratio | GCST90314563 | 12.30 |
| 711 | CCL17 levels | GCST90468569 | 12.29 |
| 712 | BAX levels | GCST90468424 | 12.28 |
| 713 | GOPC levels | GCST90469377 | 12.27 |
| 714 | MAP2K6/TBL1X ratio | GCST90315378 | 12.27 |
| 715 | TXLNA levels | GCST90470989 | 12.26 |
| 716 | DNAJB14 levels | GCST90469011 | 12.23 |
| 717 | DNAJB1 levels | GCST90469012 | 12.19 |
| 718 | CCL5/CXCL3 ratio | GCST90313700 | 12.17 |
| 719 | ITGB5/VSIR ratio | GCST90315235 | 12.17 |
| 720 | PRKAR2A levels | GCST90470327 | 12.16 |
| 721 | BTN3A2 levels | GCST90468481 | 12.15 |
| 722 | APP/BIN2 ratio | GCST90313316 | 12.14 |
| 723 | PDLIM7 levels | GCST90470198 | 12.14 |
| 724 | CD69/CLEC1B ratio | GCST90313869 | 12.10 |
| 725 | ACOX1/VSIR ratio | GCST90313155 | 12.08 |
| 726 | CANT1 levels | GCST90468536 | 12.05 |
| 727 | BECN1 levels | GCST90468438 | 12.05 |
| 728 | BA-exvivo lh area BA2 | GCST90003208 | 12.03 |
| 729 | STK24 levels | GCST90470766 | 12.03 |
| 730 | NFE2 levels | GCST90470035 | 12.02 |
| 731 | EHD3 levels | GCST90469089 | 12.01 |
| 732 | CALCOCO1/IKBKG ratio | GCST90313602 | 12.01 |
| 733 | Mean corpuscular hemoglobin concentration | GCST004605 | 12.01 |
| 734 | PDGFB/TIMP3 ratio | GCST90315631 | 12.00 |
| 735 | FUT8/RSPO1 ratio | GCST90314891 | 11.97 |
| 736 | Drive faster than motorway speed limit | Physical activity | UKBB00000194 | 11.95 |
| 737 | CD244/EDAR ratio | GCST90313764 | 11.95 |
| 738 | FXYD5/TMSB10 ratio | GCST90314906 | 11.92 |
| 739 | HBEGF levels | GCST90241392 | 11.92 |
| 740 | neutrophil (absolute count, mean, inv-norm transformed) | GCST90475529 | 11.90 |
| 741 | MSRA/SNAP29 ratio | GCST90315500 | 11.89 |
| 742 | White blood cell count (basophil) | GCST004618 | 11.89 |
| 743 | WASF1 levels | GCST90471067 | 11.85 |
| 744 | T1 FreeSurfer a2009s rh G&S subcentral volume | GCST90385041 | 11.83 |
| 745 | Coffee type - Instant coffee | Diet | UKBB00000141 | 11.82 |
| 746 | DBI/EDAR ratio | GCST90314408 | 11.81 |
| 747 | EDAR/SNAP23 ratio | GCST90314587 | 11.79 |
| 748 | Cognitive performance | GCST006572 | 11.79 |
| 749 | TIMP3/ZBTB16 ratio | GCST90315921 | 11.78 |
| 750 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 11.78 |
| 751 | FUT8/SPARC ratio | GCST90314893 | 11.77 |
| 752 | EIF4G1/MAVS ratio | GCST90314636 | 11.77 |
| 753 | Immature fraction of reticulocytes | GCST004628 | 11.76 |
| 754 | ITGA6 levels | GCST90469636 | 11.73 |
| 755 | CIAPIN1/VEGFC ratio | GCST90314071 | 11.70 |
| 756 | CD40/ITGB5 ratio | GCST90313816 | 11.70 |
| 757 | NT5C levels | GCST90470092 | 11.69 |
| 758 | MPIG6B/PDGFB ratio | GCST90315482 | 11.62 |
| 759 | HSBP1 levels | GCST90469481 | 11.62 |
| 760 | ACRBP levels | GCST90468205 | 11.61 |
| 761 | PPP2R5A levels | GCST90470306 | 11.60 |
| 762 | CHMP1A/EREG ratio | GCST90314048 | 11.59 |
| 763 | ICA1 levels | GCST90469497 | 11.59 |
| 764 | Cholesteryl ester_14:0_[M+NH4]1+ levels | GCST90060197 | 11.59 |
| 765 | CDKN2D/MANF ratio | GCST90313989 | 11.59 |
| 766 | IPCEF1/SERPINE1 ratio | GCST90315184 | 11.58 |
| 767 | CA13/QDPR ratio | GCST90313564 | 11.56 |
| 768 | BIN2 levels | GCST90468445 | 11.55 |
| 769 | Bread intake | Diet | UKBB00000105 | 11.54 |
| 770 | FABP5 levels | GCST90469177 | 11.54 |
| 771 | MAVS/PPP1R9B ratio | GCST90315393 | 11.51 |
| 772 | 5-oxoproline levels | GCST90243437 | 11.50 |
| 773 | CD40LG/EGF ratio | GCST90313819 | 11.49 |
| 774 | Apple juice liking | GCST90094690 | 11.48 |
| 775 | TNFSF14 levels | GCST90470922 | 11.47 |
| 776 | BCR/GOPC ratio | GCST90313491 | 11.46 |
| 777 | RILP levels | GCST90470471 | 11.43 |
| 778 | PPP1R12A/SPARC ratio | GCST90315712 | 11.43 |
| 779 | CLEC1B levels | GCST90468768 | 11.40 |
| 780 | DCTN1 levels | GCST90468958 | 11.39 |
| 781 | ENO2/MGLL ratio | GCST90314663 | 11.39 |
| 782 | DCTN6 levels | GCST90468960 | 11.36 |
| 783 | DBNL/EDAR ratio | GCST90314416 | 11.36 |
| 784 | Left-hemisphere visual network to thalamus white-matter structural connectivity | GCST90302662 | 11.34 |
| 785 | ARF6 levels | GCST90468348 | 11.34 |
| 786 | ITGAM/ITGAV ratio | GCST90315209 | 11.32 |
| 787 | RHOC/TBCC ratio | GCST90315775 | 11.31 |
| 788 | BRK1 levels | GCST90468469 | 11.30 |
| 789 | ERMAP levels | GCST90469147 | 11.29 |
| 790 | Physical activity (Total log acceleration 8pm-10pm) | GCST90061419 | 11.29 |
| 791 | Ever depressed for a whole week | Mental health | UKBB00000214 | 11.29 |
| 792 | aparc-a2009s rh area S-subparietal | GCST90003441 | 11.28 |
| 793 | PDGFB levels | GCST90012016 | 11.28 |
| 794 | CRYBB1 levels | GCST90468874 | 11.26 |
| 795 | CD40/IGSF8 ratio | GCST90313815 | 11.25 |
| 796 | Principal component-derived dietary pattern 52 | GCST90133056 | 11.23 |
| 797 | Amyotrophic lateral sclerosis | GCST90027164 | 11.22 |
| 798 | PRDX3 levels | GCST90470317 | 11.22 |
| 799 | PECAM1 levels | GCST90470206 | 11.21 |
| 800 | PCYT2 levels | GCST90470178 | 11.19 |
| 801 | CCL17/F2R ratio | GCST90313686 | 11.15 |
| 802 | Cough (PheCode 512.8) | GCST90476041 | 11.14 |
| 803 | Cheese intake | Diet | UKBB00000127 | 11.13 |
| 804 | CLEC1B/LGALS8 ratio | GCST90314096 | 11.13 |
| 805 | PTGES2 levels | GCST90470369 | 11.12 |
| 806 | CNST/ITGB1BP2 ratio | GCST90314158 | 11.12 |
| 807 | MAX/STK24 ratio | GCST90315404 | 11.06 |
| 808 | GPI levels | GCST90469391 | 11.06 |
| 809 | MMP8 levels | GCST90469922 | 11.05 |
| 810 | CASP10/ING1 ratio | GCST90313625 | 11.03 |
| 811 | SIAE/SNAP29 ratio | GCST90315843 | 11.01 |
| 812 | GOLGA3 levels | GCST90469375 | 10.99 |
| 813 | Intelligence | GCST90179114 | 10.99 |
| 814 | White blood cell count | GCST90002374 | 10.96 |
| 815 | SUGT1/TBL1X ratio | GCST90315897 | 10.92 |
| 816 | AAMDC levels | GCST90468186 | 10.92 |
| 817 | F-capsicum liking (derived food-liking factor) | GCST90094726 | 10.92 |
| 818 | Own or rent accommodation lived in - Rent - from local authority, local council, housing association | Household | UKBB00000624 | 10.91 |
| 819 | SH2B3/SUGT1 ratio | GCST90315840 | 10.91 |
| 820 | Basophil count | GCST90002379 | 10.89 |
| 821 | AZU1/MPO ratio | GCST90313425 | 10.87 |
| 822 | MAP2K6 levels | GCST90469852 | 10.86 |
| 823 | CC2D1A/TMSB10 ratio | GCST90313667 | 10.82 |
| 824 | F2R/ITGB1BP2 ratio | GCST90314731 | 10.80 |
| 825 | Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary Administration | UKBB00000466 | 10.79 |
| 826 | HTRA2/TRIAP1 ratio | GCST90315099 | 10.78 |
| 827 | APBB1IP levels | GCST90468327 | 10.78 |
| 828 | P4HB levels | GCST90470140 | 10.77 |
| 829 | NEXN levels | GCST90470030 | 10.76 |
| 830 | USP8/WASF1 ratio | GCST90315944 | 10.74 |
| 831 | DNM3 levels | GCST90469022 | 10.74 |
| 832 | CCL13/CCL17 ratio | GCST90313674 | 10.74 |
| 833 | Bread intake (UKB data field 1438) | GCST90468162 | 10.73 |
| 834 | DAPK2 levels | GCST90468945 | 10.70 |
| 835 | IRAK1 levels | GCST90469627 | 10.70 |
| 836 | ARHGAP45 levels | GCST90468355 | 10.67 |
| 837 | EGLN1/FOXO1 ratio | GCST90314616 | 10.66 |
| 838 | CLEC1B/SNAP29 ratio | GCST90314103 | 10.65 |
| 839 | ING1 levels | GCST90469613 | 10.63 |
| 840 | MINDY1 levels | GCST90469908 | 10.62 |
| 841 | PLXNA4/SPRY2 ratio | GCST90315687 | 10.59 |
| 842 | CXCL11 levels | GCST90468924 | 10.59 |
| 843 | Physical activity (Total log acceleration) | GCST90061408 | 10.57 |
| 844 | SLA2 levels | GCST90470648 | 10.56 |
| 845 | AKT2 levels | GCST90468277 | 10.55 |
| 846 | CD244/TREML2 ratio | GCST90313767 | 10.54 |
| 847 | CLEC1B/MGLL ratio | GCST90314097 | 10.53 |
| 848 | Mouth/teeth dental problems - Bleeding gums | Mouth | UKBB00000485 | 10.52 |
| 849 | TOMM20 levels | GCST90470931 | 10.51 |
| 850 | Red blood cell erythrocyte distribution width (UKB data field 30070) | GCST90468099 | 10.50 |
| 851 | monocyte (fraction, mean, inv-norm transformed) | GCST90475511 | 10.50 |
| 852 | Cake icing liking | GCST90094723 | 10.49 |
| 853 | ESYT2 levels | GCST90469156 | 10.48 |
| 854 | Hearing difficulty/problems with background noise | Hearing | UKBB00000312 | 10.47 |
| 855 | TEK levels | GCST90012013 | 10.46 |
| 856 | Frailty (Factor 5 - Poorer Cognition) | GCST90624051 | 10.45 |
| 857 | OTUD7B levels | GCST90470137 | 10.45 |
| 858 | EIF4G1/HEXIM1 ratio | GCST90314635 | 10.44 |
| 859 | Cheese consumption | GCST90133000 | 10.43 |
| 860 | NAA80 levels | GCST90469990 | 10.43 |
| 861 | PPIF levels | GCST90470293 | 10.41 |
| 862 | ENO2/ITGB1BP2 ratio | GCST90314661 | 10.41 |
| 863 | MTSS2 levels | GCST90469961 | 10.41 |
| 864 | FEN1 levels | GCST90469213 | 10.40 |
| 865 | NUMB levels | GCST90470108 | 10.38 |
| 866 | IGSF8/VSIR ratio | GCST90315141 | 10.38 |
| 867 | Hearing difficulty problems background noise (UKB data field 2257) | GCST90042885 | 10.38 |
| 868 | Mean corpuscular hemoglobin concentration | GCST90002391 | 10.37 |
| 869 | TNFRSF11B levels | GCST90243158 | 10.36 |
| 870 | ABHD14B levels | GCST90468189 | 10.35 |
| 871 | Job involves mainly walking or standing | Employment | UKBB00000384 | 10.31 |
| 872 | Coffee type: Instant coffee (UKB data field 1508_2) | GCST90041802 | 10.31 |
| 873 | Mean corpuscular hemoglobin concentration | GCST90002328 | 10.28 |
| 874 | EGLN1/PIK3AP1 ratio | GCST90314619 | 10.28 |
| 875 | MTIF3 levels | GCST90469957 | 10.26 |
| 876 | RAB11FIP3 levels | GCST90470404 | 10.24 |
| 877 | Feeling guilty | GCST006945 | 10.19 |
| 878 | EGF/MPIG6B ratio | GCST90314611 | 10.19 |
| 879 | KAZN levels | GCST90469666 | 10.18 |
| 880 | Glycated haemoglobin HbA1c levels (UKB data field 30750) | GCST90468072 | 10.17 |
| 881 | CXCL10/CXCL11 ratio | GCST90314330 | 10.17 |
| 882 | Loneliness, isolation | Mental health | UKBB00000408 | 10.16 |
| 883 | MANF/PTPN6 ratio | GCST90315366 | 10.16 |
| 884 | BA-exvivo lh volume BA2 | GCST90002836 | 10.15 |
| 885 | MANF/PRDX5 ratio | GCST90315365 | 10.15 |
| 886 | STIP1 levels | GCST90470764 | 10.15 |
| 887 | CIAPIN1/SNX9 ratio | GCST90314068 | 10.13 |
| 888 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 10.13 |
| 889 | MGLL/PDLIM7 ratio | GCST90315438 | 10.10 |
| 890 | Sleep disorders | neurological | UKBB00000776 | 10.10 |
| 891 | QDPR levels | GCST90470400 | 10.08 |
| 892 | TYMP levels | GCST90470996 | 10.07 |
| 893 | IDP dMRI ProbtrackX L1 cgc l | GCST90004250 | 10.07 |
| 894 | FKBP4 levels | GCST90469243 | 10.07 |
| 895 | MPHOSPH8 levels | GCST90469934 | 10.05 |
| 896 | PIBF1 levels | GCST90470231 | 10.04 |
| 897 | Neuroticism | GCST002920 | 10.03 |
| 898 | CCL22/TIMP3 ratio | GCST90313693 | 10.02 |
| 899 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 10.02 |
| 900 | FLI1 levels | GCST90469247 | 10.01 |
| 901 | CASP2 levels | GCST90468544 | 10.01 |
| 902 | VASH1 levels | GCST90471026 | 9.99 |
| 903 | RTN4IP1 levels | GCST90470507 | 9.99 |
| 904 | MCFD2/VSIR ratio | GCST90315411 | 9.98 |
| 905 | LATS1 levels | GCST90469740 | 9.97 |
| 906 | BCR/ITGB1BP2 ratio | GCST90313494 | 9.96 |
| 907 | Basophil percentage of granulocytes | GCST004634 | 9.96 |
| 908 | DTYMK levels | GCST90469049 | 9.95 |
| 909 | IDP dMRI TBSS L2 Anterior corona radiata L | GCST90004146 | 9.94 |
| 910 | DKK1/PDGFA ratio | GCST90314475 | 9.92 |
| 911 | CLEC5A levels | GCST90468776 | 9.90 |
| 912 | CD69/TXNDC5 ratio | GCST90313889 | 9.89 |
| 913 | GGCT levels | GCST90469334 | 9.89 |
| 914 | RNF5 levels | GCST90470488 | 9.89 |
| 915 | DFFA/FOXO1 ratio | GCST90314456 | 9.88 |
| 916 | SPARC/TACC3 ratio | GCST90315872 | 9.88 |
| 917 | CHMP6 levels | GCST90468747 | 9.84 |
| 918 | DKK1/PTPN6 ratio | GCST90314478 | 9.83 |
| 919 | Reticulocyte count | GCST90025972 | 9.82 |
| 920 | Triacylglycerol (54:0) [NL-18:0] levels | GCST90025173 | 9.81 |
| 921 | Current employment status - Doing unpaid or voluntary work | Employment | UKBB00000157 | 9.79 |
| 922 | APRT/PSME1 ratio | GCST90313338 | 9.78 |
| 923 | CHMP1A levels | GCST90468746 | 9.78 |
| 924 | DTI TBSS L3 Cingulum hippocampus R | GCST90384560 | 9.76 |
| 925 | Vanillylmandelate (VMA) levels | GCST90200309 | 9.75 |
| 926 | ARSB levels | GCST90468369 | 9.73 |
| 927 | White blood cell (leukocyte) count | Blood count | UKBB00000913 | 9.73 |
| 928 | IGFBP6/PTGDS ratio | GCST90315137 | 9.72 |
| 929 | PPP1R2/TMSB10 ratio | GCST90315721 | 9.69 |
| 930 | SH2B3/TBL1X ratio | GCST90315841 | 9.69 |
| 931 | LGMN/SPINT2 ratio | GCST90315324 | 9.68 |
| 932 | Sources of admission to hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000786 | 9.68 |
| 933 | DARS1 levels | GCST90468947 | 9.68 |
| 934 | MTHFSD levels | GCST90469956 | 9.68 |
| 935 | PEAR1/SCARF1 ratio | GCST90315642 | 9.66 |
| 936 | BIRC2 levels | GCST90468446 | 9.65 |
| 937 | IDP T1 FAST ROIs V cerebellum VIIb | GCST90002576 | 9.63 |
| 938 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 9.62 |
| 939 | ALDH1A1/CA3 ratio | GCST90313244 | 9.62 |
| 940 | PTPN1 levels | GCST90470376 | 9.62 |
| 941 | TMED8 levels | GCST90470885 | 9.61 |
| 942 | DAG1/DKK1 ratio | GCST90314373 | 9.61 |
| 943 | JPT2 levels | GCST90469663 | 9.59 |
| 944 | OPHN1 levels | GCST90470126 | 9.58 |
| 945 | BANK1 levels | GCST90468421 | 9.56 |
| 946 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 9.54 |
| 947 | Beetroot liking | GCST90094702 | 9.54 |
| 948 | Parkinson's disease or first degree relation to individual with Parkinson's disease | GCST009325 | 9.50 |
| 949 | MANF/NCK2 ratio | GCST90315359 | 9.50 |
| 950 | CXCL5/MESD ratio | GCST90314350 | 9.50 |
| 951 | Dementia | FING00000391 | 9.47 |
| 952 | PPP1R12A/VEGFC ratio | GCST90315715 | 9.44 |
| 953 | ESAM/THPO ratio | GCST90314719 | 9.43 |
| 954 | SRPK2 levels | GCST90470743 | 9.42 |
| 955 | CRACR2A levels | GCST90468853 | 9.42 |
| 956 | GFAP levels | GCST90469325 | 9.42 |
| 957 | IMPA1 levels | GCST90469610 | 9.42 |
| 958 | LAT2 levels | GCST90469739 | 9.40 |
| 959 | Sleep disorders | Episodic and paroxysmal disorders | UKBB00000775 | 9.40 |
| 960 | DKK1 levels | GCST90012060 | 9.39 |
| 961 | IMPACT levels | GCST90469611 | 9.38 |
| 962 | CLEC1B/DIABLO ratio | GCST90314087 | 9.38 |
| 963 | GP1BA/SELP ratio | GCST90314958 | 9.37 |
| 964 | GAPDH levels | GCST90469302 | 9.36 |
| 965 | Common executive function | GCST90162547 | 9.35 |
| 966 | EIF4B levels | GCST90469094 | 9.34 |
| 967 | ABL1 levels | GCST90468190 | 9.34 |
| 968 | PRTN3/RETN ratio | GCST90315734 | 9.34 |
| 969 | AIF1 levels | GCST90468267 | 9.33 |
| 970 | SNCA levels | GCST90240258 | 9.33 |
| 971 | CD84/TREML2 ratio | GCST90313919 | 9.32 |
| 972 | Common executive function | GCST90503115 | 9.30 |
| 973 | CASP8/SEPTIN9 ratio | GCST90313658 | 9.29 |
| 974 | BID levels | GCST90468444 | 9.28 |
| 975 | SLMAP levels | GCST90470673 | 9.27 |
| 976 | CCL5/TFPI ratio | GCST90313708 | 9.26 |
| 977 | SERPINB8 levels | GCST90470592 | 9.25 |
| 978 | STX8 levels | GCST90470776 | 9.23 |
| 979 | EDAR/TNFSF12 ratio | GCST90314591 | 9.22 |
| 980 | PRKRA levels | GCST90470331 | 9.20 |
| 981 | ITGB2 levels | GCST90469644 | 9.20 |
| 982 | Feeling fed-up | GCST006947 | 9.18 |
| 983 | Other venous embolism and thrombosis (PheCode 452) | GCST90476007 | 9.16 |
| 984 | EGLN1/PSIP1 ratio | GCST90314620 | 9.13 |
| 985 | Coffee difference liking | GCST90094738 | 9.10 |
| 986 | PDGFB/PTPN6 ratio | GCST90315625 | 9.09 |
| 987 | CRYGD levels | GCST90468876 | 9.09 |
| 988 | White blood cell count | GCST004610 | 9.08 |
| 989 | PLA2G4A/SNAP29 ratio | GCST90315669 | 9.08 |
| 990 | PPP3R1 levels | GCST90470307 | 9.06 |
| 991 | OXCT1 levels | GCST90470138 | 9.05 |
| 992 | VASP levels | GCST90471028 | 9.02 |
| 993 | LAG3 levels | GCST90469727 | 9.01 |
| 994 | INPPL1 levels | GCST90469619 | 9.01 |
| 995 | PDLIM7/SRC ratio | GCST90315639 | 9.01 |
| 996 | Cognitive processing speed | GCST90446168 | 9.00 |
| 997 | white blood cell count (WBC, mean, inv-norm transformed) | GCST90476454 | 8.98 |
| 998 | NFATC1 levels | GCST90470033 | 8.95 |
| 999 | Physical activity (Total log acceleration 6pm-8pm) | GCST90061418 | 8.95 |
| 1000 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475462 | 8.95 |